Ticker NLTX – Aquinox Pha – sales, description, marketcap – Tickerday.com

NLTX

Aquinox Pha

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 491.80M; Volume: 55.04K; AvgVol 3m: 320.60K; Beta: 0.96;

Cost estimate:

P/E: –; EPS: -2.86; EPS growth quarter/prev quarter: ;

EPS growth this year: -91.30%; EPS growth past 5 years: 1.30%;

EPS ttm: -2.86;

P/S: ; P/B: 4.78; P/Cashflow: 04.01; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -66.50%; ROE – return on equity: -72.20%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 22.09%; Insider Transactions:0.00%;

Institutional Ownership: 60.50%; Institutional Transactions: 10.93%;

Data update: 07/10/2020.